Human Resources Online9d
Q&A: A transformation journey like no other, by Joan Ronquillo-Cuevas, P&C Head for the Asia East Cluster, PMI
Operating in a highly matrixed organisational structure, the Philip Morris International HR leader is committed to delivering ...
Investing29d
Philip Morris stock rises on FDA's first nicotine pouch approval
Investing.com -- Shares of Philip ... who use cigarettes and/or smokeless tobacco products completely switched to the newly authorized nicotine pouch products. Matthew Farrelly, Ph.D., director ...
Inquirer on MSN4h
PH harm reduction advocates welcome US FDA marketing authorizations for ZYN
Local proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...
manilastandard22h
US FDA marketing authorizations for Zyn encourage Filipino harm reduction advocates
Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...
Investing8d
Philip Morris International stock jumps on strong Q4 revenue
For 2025, Philip Morris forecasts adjusted EPS of $7.04 to $7.17, representing 7.2% to 9.1% growth over 2024. The company ...
business-review.eu17d
Philip Morris International announces that the U.S. Food and Drug Administration have authorized the marketing of ZYN Nicotine Pouch Products
“It’s critical that the manufacturer market these products responsibly to prevent youth use,” said Brian King ... to cigarettes and other tobacco products for adult smokers”, said Mihai Bundoi, Head ...
Manila Bulletin29d
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
(AP Photo/Bebeto Matthews, File) WASHINGTON (AP) — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help ...